A European phase III study of Pollinex Quattro® Birch

Trial Profile

A European phase III study of Pollinex Quattro® Birch

Phase of Trial: Phase III

Latest Information Update: 18 Jul 2016

At a glance

  • Drugs Tree pollen allergy immunotherapies (Primary)
  • Indications Tree pollen hypersensitivity
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergy Therapeutics
  • Most Recent Events

    • 18 Jul 2016 New trial record
    • 13 Jul 2016 According to an Allergy Therapeutics media release, this study is planned to start in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top